Senior Director Novo Nordisk Cambridge, United Kingdom
Join Annette Bak, Sanya Puri, and several authors in Poster Forum #4 in the Solution Center (Exhibit Halls 3 & 4) for a conversation about posters on the topic, “RNA/DNA Non-Viral Delivery”, that they are especially excited about.
T0930-05-28 Cellular Mechanisms Underlying Species-Related Differences in Effective Delivery of LNP-mRNA, Kari Martyniak, Ph.D., Pfizer, Inc.
T1330-07-46 Evaluation of Next-Generation Lipids with Varying Chemistries for Enhancing the Endosomal Escape and Extrahepatic Delivery Potential of mRNA-LNP Therapeutics, Aishwarya Saraswat, Ph.D., Regeneron Pharmaceuticals
W1230-09-55 Formulation Development of Novel T-Cell Targeting Ligand-Conjugated Lipid Nanoparticles for In Situ CAR-T Cell Therapy Using Model mRNAs, Yutaka Nishimoto, Ph.D., Takeda Pharmaceutical Company Limited
T0930-01-03 Investigating How Ionizable Lipids Impact the Cargo RNA Organization in Lipid Nanoparticles Using Small Angle X-Ray Scattering (SAXS), Viswanathan Gurumoorthy, Ph.D., Merck & Co., Inc.
M1130-01-06 Challenges and Solutions in Ion-Pair Reversed-Phase LC–MS/MS Assays for the Quantitation of Novel Oligonucleotides: A Case Study, Andy (Hongfang) Xue, MS, Resolian
